Treatment with MG132 prevents spontaneous activation of rat oocyte in culture and promotes embryonic development after intracytoplasmic sperm injection

• Published in: Scientific reports Vol. 12; no. 1; pp. 2706 - 8
• Main Authors: Nakagawa, Yuki, Kaneko, Takehito
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 17.02.2022; Nature Publishing Group; Nature Portfolio
• Subjects: 631/61; 631/61/17; Animals; Blastocysts; Chorionic Gonadotropin - pharmacology; Chorionic Gonadotropin - therapeutic use; Chromosomes - drug effects; Embryogenesis; Embryonic Development - drug effects; Embryonic growth stage; Female; Humanities and Social Sciences; Injection; Leupeptins - pharmacology; Leupeptins - therapeutic use; Male; multidisciplinary; Offspring; Oocytes; Oocytes - cytology; Oocytes - drug effects; Oviduct; Proteasome inhibitors; Rats; Rats, Wistar; Science; Science (multidisciplinary); Sperm; Sperm Injections, Intracytoplasmic - drug effects; Sperm Injections, Intracytoplasmic - methods; Spermatozoa - drug effects; Time Factors
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-022-06714-6

Intracytoplasmic sperm injection (ICSI) is an effective reproductive technique for obtaining rat offspring using preserved sperm with low or no motility. However, rat oocytes undergo spontaneous activation immediately after retrieval from the oviduct and poorly develop after ICSI unless it is performed quickly. Here, we evaluated whether treatment with MG132, the proteasome inhibitor, suppresses the spontaneous activation of oocytes before and during ICSI. After retrieval from the oviducts, the rate of development into morula and blastocyst from the oocytes cultured in vitro for 1 h prior to ICSI significantly decreased compared with that from the control oocytes subject to ICSI without culture (7% versus 36%). However, a higher proportion of oocytes treated with MG132 for 0, 1, and 3 h before and during ICSI developed into morulae and blastocysts (70%, 60%, and 52%, respectively). Offspring were obtained from oocytes treated with MG132 for 0 and 1 h before and during ICSI (percentage: 31%). Altogether, MG132 could suppress the spontaneous activation of rat oocytes and increase embryonic development after ICSI.